You are here » News


December 07, 2015

Mumbai, December 7, 2015 - Galderma a global leader in dermatology is further strengthening its presence in the aesthetic and corrective dermatology market in India by announcing the launch of Emervel range.  

The aesthetic and corrective market is rapidly growing with an increased demand amongst people to look and feel good by ageing gracefully. In alignment with this growing demand, Galderma India is adding the Emervel range to its filler portfolio. Galderma India now offers a complementary range of fillers, Restylane and Emervel, for varying aesthetic requirements of patients. The Restylane range of fillers are used for defining, shaping and contouring the facial features such as jawline enhancement, high cheek bone effect and filling out deep lines and wrinkles. Emervel is an innovative soft dermal filler specifically designed to enhance patient tolerability and provide long‐lasting correction of facial lines and volume loss or lip enhancement. An additional advantage of the filler products - Restylane and Emervel is that they offer a painless treatment due to the presence of local anaesthetic, lidocaine.       

The two variants launched in this category are Emervel Volume and Emervel Lips. Emervel Volume helps restore volume in facial areas such as cheeks and chin. Emervel Lips is a specially designed product for the restoration and/or augmentation of the volume of lips. In fact, Emervel Lips is the first and only filler product in India specially designed for redefining lips. The trend to enhance and define lips is on the rise as is clearly depicted through the booming need to look good and refreshed.

“The launch of Emervel range will help Health Care practitioners customize their treatments, depending on the patients’ skin, tissue and volume conditions. Emervel range also provides the patients with Emervel Lips, a product specifically designed for volumizing and enhancing lips. We endeavor to continue to launch such new and innovative products that will enable doctors to best address skin senescence and individual patient requirements. We take pride in our training and education that we develop with our physicians,” said Mr. G Sathya Narayanan, MD Galderma South Asia.

About Galderma:
Dating back to 1961, Galderma is now present in 80 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with Health Care Professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin, hair and nails.

Strategic brands in India include Epiduo®, Adaferin®, Tri-Luma® RD, Loceryl®, Cetaphil®, and Restylane®.

Media Contact Person: Parag Dhurke
Agency Name: Glocal PR
Contact No: 9769686011

Posted in: Press release

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world



We are committed

See all videos